Company Profile
Stereotaxis Stock Price, News & Analysis
- Ticker:
- STXS
- Exchange:
- AMEX
- Sector:
- Biopharma
- Location:
- United States
Stock performance
1.36 USD (-2.16%)
Close
Last updated: August 6, 2026
193M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, STXS closed down 2.16% at $1.36. No new same-company headline was identified in the current news window.
Company overview
Endovascular Surgical Robotics
Stereotaxis develops robotic systems, instruments, and software for minimally invasive endovascular procedures.
Magnetic Navigation
Its robotic magnetic navigation platform allows physicians to steer compatible catheters through the heart with precise remote control.
Integrated Procedure Suite
The MAGiC robotically navigated catheter and Synchrony digital operating-room system extend Stereotaxis from capital equipment into proprietary instruments and workflow software.
Broader Robotics Strategy
The planned Robocath acquisition would combine complementary robotic technologies across cardiac and vascular intervention.
Future catalysts
Stereotaxis’s catalysts are robotic catheter adoption, system placements, and growth in electrophysiology workflow. The market will care about whether the technology can keep winning procedure share.
Recent news
- 01
- 02
University of Szeged Pioneers First Robotic Cardiology Program in Hungary
Source: Stereotaxis
- 03
Stereotaxis Completes Acquisition of Robocath
Source: Stereotaxis
- 04
Stereotaxis Reports 2026 First Quarter Financial Results & Business Updates
Source: Stereotaxis
- 05
Stereotaxis Announces First MAGiC Procedures in the United States
Source: Stereotaxis
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Stereotaxis (STXS)?
Stereotaxis (STXS) most recently closed at 1.36 USD, a -2.16% move versus the previous session.
What is the market cap of Stereotaxis (STXS)?
Stereotaxis currently has a market capitalization of 193M USD on BioPharmSignal.
What does Stereotaxis do?
Endovascular Surgical Robotics Stereotaxis develops robotic systems, instruments, and software for minimally invasive endovascular procedures. Magnetic Navigation Its robotic magnetic navigation platform allows physicians to steer compatible catheters through the heart with precise remote control. Integrated Procedure Suite The MAGiC robotically navigated...
On which exchange is STXS stock listed?
Stereotaxis (STXS) is associated with AMEX, United States, Biopharma.
What is Endovascular?
Endovascular Surgical Robotics Stereotaxis develops robotic systems, instruments, and software for minimally invasive endovascular procedures.
Which conditions is Stereotaxis targeting with Endovascular?
Endovascular Surgical Robotics Stereotaxis develops robotic systems, instruments, and software for minimally invasive endovascular procedures. Magnetic Navigation Its robotic magnetic navigation platform allows physicians to steer compatible catheters through the heart with precise remote control. Integrated Procedure Suite The MAGiC robotically navigated...
How does Stereotaxis describe recent progress with Endovascular?
Stereotaxis’s catalysts are robotic catheter adoption, system placements, and growth in electrophysiology workflow. The market will care about whether the technology can keep winning procedure share.
What is Surgical?
Endovascular Surgical Robotics Stereotaxis develops robotic systems, instruments, and software for minimally invasive endovascular procedures.